DC
LSTA icon

Deere & Company’s Lisata Therapeutics LSTA Stock Holding History

Deere & Company’s Portfolio LSTA Stock Details LSTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-307
Closed -$325K – 996
2014
Q1 		$325K Sell
307
-104
-25% -$113K 0.02% 716
2013
Q4 		$420K Buy
411
+90
+28% +$89K 0.02% 698
2013
Q3 		$412K Buy
+321
New +$356K 0.02% 706

Other funds holding LSTA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
BIM
BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return

Deere & Company's LSTA Position: Q2 2014 in Review

Deere & Company sold out of Lisata Therapeutics (LSTA) in Q2 2014, closing a stake of 307 shares — an estimated $325K sold.

Deere & Company first reported a position in LSTA in Q3 2013 and held it in 3 quarters. The position peaked at $420K in Q4 2013. 58 funds tracked by Wall St. Rank hold LSTA as of Q2 2014.

  • Deere & Company reported no remaining Lisata Therapeutics position as of Q2 2014 after selling out during the quarter.
  • Deere & Company sold 307 Lisata Therapeutics shares in Q2 2014, an estimated $325K.
  • Deere & Company first reported a position in Lisata Therapeutics in Q3 2013 and held it in 3 quarters.
  • Deere & Company's Lisata Therapeutics position peaked at $420K in Q4 2013.
  • 58 funds tracked by Wall St. Rank held Lisata Therapeutics as of Q2 2014.

Based on Deere & Company's 13F filing for Q2 2014, filed 11 Aug 2014.